Dear Women's Imaging Insider,
More and more clinical evidence suggests that using digital breast tomosynthesis (DBT) for breast cancer screening reduces recall rates and increases cancer detection. At the recent European Congress of Radiology (ECR), Italian researchers added another benefit to the technology's list: DBT helps breast imagers categorize lesions more accurately -- which can lead to downstream benefits such as decreased patient anxiety and more cost-effective treatment.
Learn more in our Insider Exclusive, which is available to you first as an Insider subscriber.
When you're done with our featured article, take a look at what else is going on in the Women's Imaging Community, including additional coverage from ECR 2017:
- Find out why sending women direct invitations for breast MRI boosts screening rates.
- Learn why uterine fibroid embolization is underutilized when it comes to treating fibroids.
- Discover how DBT reduces breast surgery re-excision rates.
- Check out what Swiss researchers have to say about whether neural networks can read mammograms as well as radiologists can.
- Is DBT ready to replace digital mammography for screening? Find out how European radiologists are addressing the question.
And of course, if you have a comment, report, or article idea to share about any aspect of women's imaging, please contact me.
